Based on the data, I would recommend a BUY. Here's why:

* The trailing and forward PEs are relatively low at around 9, indicating that the stock is undervalued.
* The ROE is decent at 13.9%, indicating that the company is generating decent returns on equity.
* The revenue growth is moderate at 15.9%, and the earnings growth is strong at 67.2%, indicating that the company's fundamentals are improving.
* Although the debt-to-equity ratio is relatively high at 53.06%, the company's profitability and growth prospects suggest that it can manage its debt levels.

Overall, the stock appears to be undervalued and has strong growth prospects, making it an attractive buy opportunity.